| SPIRIT 2013 statement: defining standard protocol items for clinical trials AW Chan, JM Tetzlaff, DG Altman, A Laupacis, PC Gøtzsche, ... Annals of internal medicine 158 (3), 200-207, 2013 | 6180 | 2013 |
| The CARE guidelines: consensus-based clinical case reporting guideline development JJ Gagnier, G Kienle, DG Altman, D Moher, H Sox, D Riley Global advances in health and medicine 2 (5), 38-43, 2013 | 2751 | 2013 |
| Clinical trial registration: a statement from the International Committee of Medical Journal Editors C De Angelis, JM Drazen, FA Frizelle, C Haug, J Hoey, R Horton, S Kotzin, ... The Lancet 364 (9438), 911-912, 2004 | 2454 | 2004 |
| On the elicitation of preferences for alternative therapies BJ McNeil, SG Pauker, HC Sox Jr, A Tversky New England journal of medicine 306 (21), 1259-1262, 1982 | 2236 | 1982 |
| Medical decision making HC Sox, MC Higgins, DK Owens, GS Schmidler John Wiley & Sons, 2024 | 1907 | 2024 |
| CARE guidelines for case reports: explanation and elaboration document DS Riley, MS Barber, GS Kienle, JK Aronson, T von Schoen-Angerer, ... Journal of clinical epidemiology 89, 218-235, 2017 | 1573 | 2017 |
| Clinical prediction rules. Applications and methodological standards. JH Wasson, HC Sox, RK Neff, L Goldman The New England journal of medicine 313 (13), 793-799, 1985 | 1447 | 1985 |
| Sponsorship, authorship, and accountability F Davidoff, CD DeAngelis, JM Drazen, J Hoey, L Højgaard, R Horton, ... The Lancet 358 (9285), 854-856, 2001 | 848 | 2001 |
| Medical professionalism in the new millennium: a physician charter H Sox Annals of internal medicine 136, 243-246, 2002 | 752 | 2002 |
| Comparative effectiveness research: a report from the Institute of Medicine HC Sox, S Greenfield Annals of internal medicine 151 (3), 203-205, 2009 | 633 | 2009 |
| The CARE guidelines: consensus-based clinical case report guideline development JJ Gagnier, G Kienle, DG Altman, D Moher, H Sox, D Riley, CARE group Journal of clinical epidemiology 67 (1), 46-51, 2014 | 618 | 2014 |
| Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors CD De Angelis, JM Drazen, FA Frizelle, C Haug, J Hoey, R Horton, ... The Lancet 365 (9474), 1827-1829, 2005 | 606 | 2005 |
| Good practices for real‐world data studies of treatment and/or comparative effectiveness: recommendations from the joint ISPOR‐ISPE Special Task Force on real‐world evidence in … ML Berger, H Sox, RJ Willke, DL Brixner, HG Eichler, W Goettsch, ... Value in Health 20 (8), 1003-1008, 2017 | 571 | 2017 |
| The erythrocyte sedimentation rate. Guidelines for rational use. HC Sox Jr, MH Liang Annals of internal medicine 104 (4), 515-523, 1986 | 555 | 1986 |
| Diagnostic decision: probability theory in the use of diagnostic tests: an introduction to critical study of the literature HC SOX Jr Annals of Internal Medicine 104 (1), 60-66, 1986 | 512 | 1986 |
| Institute of Medicine R Ratner, J Eden, D Wolman, S Greenfield, H Sox Initial national priorities for comparative effectiveness research …, 2009 | 504* | 2009 |
| Clinical trial registration: looking back and moving ahead C Laine, R Horton, CD DeAngelis, JM Drazen, FA Frizelle, F Godlee, ... The Lancet 369 (9577), 1909-1911, 2007 | 500 | 2007 |
| Physicians’ views of the relative importance of thirty medical innovations VR Fuchs, HC Sox Jr Health Affairs 20 (5), 30-42, 2001 | 405 | 2001 |
| Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease LL Humphrey, BKS Chan, HC Sox Annals of internal medicine 137 (4), 273-284, 2002 | 393 | 2002 |
| Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines RF Nease, T Kneeland, GT O'Connor, W Sumner, C Lumpkins, L Shaw, ... Jama 273 (15), 1185-1190, 1995 | 367 | 1995 |